Announcing our Powered by Pablove 2020 Grant Recipients

August 11, 2020

During a time when many organizations are pausing or even cutting research funding altogether, The Pablove Foundation is proud to be stepping up on our commitment to finding a cure for kids with cancer. This year, we’ve awarded five new Powered by Pablove Childhood Cancer Seed Grants, to daring scientists across the world. Yes, this year’s innovative researchers hail from Barcelona to Texas! They truly are at the leading edge of their fields. Meet our newest 2020-2021 Powered by Pablove Researchers now…

Dr. Thais Armangue MD PhD

Institute for Biomedical Research August Pi i Sunyer, Barcelona, Spain

Studying: OMS

Project Title: Opsoclonus myoclonus syndrome: a novel approach to antigen identification and disease modeling

All the way in Barcelona, Spain, Dr. Armengue is studying a rare autoimmune condition called Opsoclonus-myoclonus Syndrome (OMS). With her Powered by Pablove funds, she’s using novel technical approaches to identify the specific antibodies involved in OMS for a more thorough understanding of how the disease develops. 

Grant funded in partnership with The Viswanatha Family + Friends.


Dr. Vicki Huff PhD

MD Anderson Cancer Center, Houston, TX

Studying: Wilms Tumor 

Project Title: Assessment of a cancer preventive agent for Wilms tumor

As a scientific researcher Dr. Huff’s work is focused on tumors of the kidneys called Wilms Tumor. There is a genetic predisposition tied to Wilms Tumor and in this Powered by Pablove Research project, Dr. Huff is studying an agent she hopes will counter the effects of that genetic predisposition to prevent the growth of Wilms Tumor in the first place! 


Dung-Fang Lee PhD

The University of Texas Health Science Center, Houston, TX

Studying: Osteosarcoma

Project Title: The Epitranscriptomic Pathway is a Therapeutic Vulnerability in p53-mutant Osteosarcoma

Osteosarcoma is among the most frequent primary malignant bone cancers in childhood and adolescence. A scientist by training, Dr. Lee is studying a genetic mutation in the p53 tumor suppressor gene to help illuminate how it contributes to the development of osteosarcoma. A successful Powered by Pablove research project will aid greatly in diagnosis or treatment of this cancer, and provide insight into personalized osteosarcoma treatment. 


Alexandra Stevens MD PhD

Baylor College of Medicine, Houston, TX

Studying: Acute Myeloid Leukemia (AML)

Project Title: Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy

Only about half the children who develop acute myelogenous leukemia will survive. A physician scientist, Dr. Stevens has identified an antibiotic that is extremely effective in the laboratory at killing AML or slowing it’s progression. With her Powered by Pablove funds, Dr. Steven will try and identify which children will derive the most benefit from including this antibiotic in their treatment plan.



Lai Man (Natalie) Wu PhD

Children’s Hospital Medical Center, Cincinnati, OH

Studying: Malignant Peripheral Nerve Sheath Tumor (MPNST)

Project Title: Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy

Neurofibromatosis type I (NF1), an inherited condition in children, affects one in every 3,000 individuals worldwide. Although benign in nature, in some cases, the slowly growing NF1-mutated nerve tumors can become malignant peripheral nerve sheath tumors (MPNST), killing 50% of the patients within five years. Dr. Wu’s Powered by Pablove research projects aim to unravel the puzzle of how benign neurofibromas (NF) become cancerous MPNST. 


Want to contribute to building a cancer-free tomorrow? Kids with cancer and the Pablove researchers speeding their cures need your support now more than ever! Every dollar you give goes a long way in our careful investment of the most urgent, life-saving ideas! Give to help us accelerate safer treatment options and cures for our kids. Donate here!